BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 31591741)

  • 1. Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment.
    Maitre E; Cornet E; Troussard X
    Am J Hematol; 2019 Dec; 94(12):1413-1422. PubMed ID: 31591741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment.
    Troussard X; Cornet E
    Am J Hematol; 2017 Dec; 92(12):1382-1390. PubMed ID: 29110361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment.
    Troussard X; Maître E; Cornet E
    Am J Hematol; 2022 Feb; 97(2):226-236. PubMed ID: 34710243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies.
    Troussard X; Maître E; Paillassa J
    Am J Hematol; 2024 Apr; 99(4):679-696. PubMed ID: 38440808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia.
    Cornet E; Delmer A; Feugier P; Garnache-Ottou F; Ghez D; Leblond V; Levy V; Maloisel F; Re D; Zini JM; Troussard X;
    Ann Hematol; 2014 Dec; 93(12):1977-83. PubMed ID: 24994538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the biology and treatment options for hairy cell leukemia.
    Jain P; Pemmaraju N; Ravandi F
    Curr Treat Options Oncol; 2014 Jun; 15(2):187-209. PubMed ID: 24652320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights in the management of patients with hairy cell leukemia.
    Cornet E; Damaj G; Troussard X
    Curr Opin Oncol; 2015 Sep; 27(5):371-6. PubMed ID: 26154707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF V600E mutation detection in hairy cell leukemia-utility of archival DNA from bone marrow aspirate/imprint smear and amplification refractory mutation system.
    Naseem S; Gupta O; Binota J; Varma N; Varma S; Malhotra P
    Mol Biol Rep; 2020 Jun; 47(6):4365-4372. PubMed ID: 32458259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow and splenic histology in hairy cell leukaemia.
    Wotherspoon A; Attygalle A; Mendes LS
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):200-7. PubMed ID: 26614898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances.
    Paillassa J; Maitre E; Troussard X
    Curr Oncol Rep; 2022 Sep; 24(9):1133-1143. PubMed ID: 35403971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and molecular characteristics and prognosis of classical hairy cell leukemia and hairy cell leukemia variant].
    Wei C; Jin XX; Cai H; Wang X; Zhuang JL; Zhou DB
    Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):416-421. PubMed ID: 37032137
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hairy cell leukemia: What are the best treatment options for relapsed or refractory patients?].
    Troussard X; Maitre E; Paillassa J
    Bull Cancer; 2021; 108(7-8):771-778. PubMed ID: 34023063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biology and Treatment of Hairy Cell Leukemia.
    Paillassa J; Troussard X
    Curr Treat Options Oncol; 2020 Apr; 21(6):44. PubMed ID: 32350628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hairy cell leukemia].
    Maitre E; Wiber M; Cornet E; Troussard X
    Presse Med; 2019; 48(7-8 Pt 1):842-849. PubMed ID: 31447330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Single-center Experience in Splenic Diffuse Red Pulp Lymphoma Diagnosis.
    Julhakyan HL; Al-Radi LS; Moiseeva TN; Danishyan KI; Kovrigina AM; Glebova SM; Lugovskaya SA; Dvirnik VN; Khvastunova AN; Yakutik IA; Savchenko VG
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S166-9. PubMed ID: 27131623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hairy cell leukaemia-variant: Disease features and treatment.
    Matutes E; Martínez-Trillos A; Campo E
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):253-63. PubMed ID: 26614904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
    Panovská A; Žák P; Jurková T; Arpáš T; Brychtová Y; Vašíková A; Hrabčáková V; Prchlíková A; Filipová M; Doubek M
    Hematol Oncol; 2024 May; 42(3):e3280. PubMed ID: 38741354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular and therapeutic advances in Hairy cell leukemia].
    Balsat M; Cornillon J
    Bull Cancer; 2013 Oct; 100(10):1043-7. PubMed ID: 24103785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novelties in the diagnostics and therapy of hairy cell leukemia].
    Sári E; Rajnai H; Dénes K; Bödör C; Csomor J; Körösmezey G; Tárkányi I; Eid H; Nagy Z; Demeter J
    Magy Onkol; 2016 Jun; 60(2):137-44. PubMed ID: 27275640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Historical overview of hairy cell leukemia.
    Andritsos LA; Grever MR
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):166-74. PubMed ID: 26614894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.